04:58 PM EDT, 03/22/2024 (MT Newswires) -- Dana Pizzuti, Chief Medical and Development Officer, on March 20, 2024, sold 15,089 shares in Crinetics Pharmaceuticals ( CRNX ) for $664,763. Following the Form 4 filing with the SEC, Pizzuti has control over a total of 27,786 shares of the company, with 27,786 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1658247/000120919124005061/xslF345X03/doc4.xml

Price: 45.13, Change: +0.84, Percent Change: +1.9